SCHEMBL10747704

SCHEMBL10747704

FC(F)(F)c1nnc(-n2[se]c3ccccc3c2=S)s1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 5/20 0.41
▸ ALDH1A1 P00352 5/20 0.40
▸ ATM Q13315 2/20 0.37
▸ OPRM1 P35372 1/20 0.33
▸ OPRL1 P41146 1/20 0.33
▸ METAP2 P50579 3/20 0.33
▸ KDM4E B2RXH2 3/20 0.33
▸ MAPT P10636 3/20 0.33
▸ NPSR1 Q6W5P4 3/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ QSOX1 O00391 1/20 0.33
▸ RGS12 O14924 1/20 0.33
▸ PMM2 O15305 1/20 0.33
▸ PLIN1 O60240 1/20 0.33
▸ GMNN O75496 1/20 0.33
▸ BBOX1 O75936 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ CYBB P04839 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10746138 0.86 ALDH1A1 (0.35) HTTALDH1A1METAP2KDM4EMAPT
SCHEMBL10764046 0.85 METAP2 (0.48) HTTALDH1A1METAP2KDM4EMAPT
SCHEMBL10746643 0.78 METAP2 (0.38) HTTALDH1A1METAP2KDM4EMAPT
SCHEMBL10745614 0.78 METAP2 (0.35) HTTALDH1A1METAP2KDM4EMAPT
SCHEMBL10749736 0.72 KDM4E (0.35) HTTALDH1A1METAP2KDM4EMAPT
SCHEMBL10744989 0.71 KAT2A (0.47) ALDH1A1KDM4ENPSR1MEN1KMT2A
SCHEMBL10502231 0.71 METAP2 (0.37) HTTALDH1A1METAP2KDM4EMAPT
SCHEMBL10501392 0.71 METAP2 (0.34) HTTALDH1A1METAP2KDM4EMAPT
SCHEMBL10748416 0.71 METAP2 (0.48) HTTALDH1A1METAP2KDM4EMAPT
SCHEMBL10502461 0.71 MAPT (0.40) HTTALDH1A1METAP2KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback